• Blog

    post #015
    December 10, 2022

    The perspective article of Bernetti et al. (vide infra) discusses expected properties of RNA binding ligands and throws light on…

    post #014
    December 8, 2022

      Pharmaceutical industries are increasingly lean on computer-aided drug design (CADD) in their pipelines. The use of CADD is crucial…

    post #013
    December 3, 2022

    #Targeting Undruggable Targets Thousand or fewer proteins have been claimed as potentially therapeutic, despite the fact that the human genome can…

    post #012
    November 30, 2022

    Tethering harmful proteins to an enzyme that triggers their destruction by the cell’s own machinery is one method of treating…

    post #011
    November 18, 2022

    Global Computer-aided Drug Discovery Market Reach $7.5 Billion by 2030 at a CAGR of 11.48% the severe coronavirus virus (COVID-19),…

    post #010
    November 17, 2022

    The expression of GPCRs that detect smell and taste has traditionally been thought to be tissue specific. However, studies over…

    post #009
    November 14, 2022

    The accurate prediction of ligand-protein binding free energies is crucial in hit identification and hit-to-lead optimization. In Binary Star, we…

    post #008
    November 11, 2022

    Undiscovered Potential of Minor CannabinoidsThe enormous therapeutic potential of minor cannabinoids is due to their interaction with central nervous system…

    post #007
    November 11, 2022

    Drug repurposing is an effective strategy in discovering or developing drug molecules with new pharmacological/therapeutic indications. In recent years, many…

    Load More

    End of Content.